Epstein Secrets

herapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National Institutes of Health officials to meet with a staffer from that company. At least as troubling are the actions Collins took that were not deemed to be ethical violation

rest. But the Republican on the ethics task force, Rep. Van Taylor of Texas, expressed no disagreement with the panel's Democrat, Pennsylvania Rep. Susan Wild, who said she expected to move "rather quickly" on writing new rules. Taylor sees the tasks as "very narrow," focused on preventing lawmakers from s

herapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National Institutes of Health officials to meet with a staffer from that company. At least as troubling are the actions Collins took that were not deemed to be ethical violation

rest. But the Republican on the ethics task force, Rep. Van Taylor of Texas, expressed no disagreement with the panel's Democrat, Pennsylvania Rep. Susan Wild, who said she expected to move "rather quickly" on writing new rules. Taylor sees the tasks as "very narrow," focused on preventing lawmakers from

Australian biotech firm, based on inside information. EFTA00085695 The office also said Collins may have broken House ethics rules by persuading National Institutes of Health officials to meet with a staffer from that company. At least as troubling are the actions Collins took that were not deemed to be ethical violation

rest. But the Republican on the ethics task force, Rep. Van Taylor of Texas, expressed no disagreement with the panel's Democrat, Pennsylvania Rep. Susan Wild, who said she expected to move "rather quickly" on writing new rules. Taylor sees the tasks as "very narrow," focused on preventing lawmakers from

herapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National Institutes of Health officials to meet with a staffer from that company. At least as troubling are the actions Collins took that were not deemed to be ethical violation

rest. But the Republican on the ethics task force, Rep. Van Taylor of Texas, expressed no disagreement with the panel's Democrat, Pennsylvania Rep. Susan Wild, who said she expected to move "rather quickly" on writing new rules. Taylor sees the tasks as "very narrow," focused on preventing lawmakers from s

herapeutics, an Australian biotech firm, based on inside information. The office also said Collins may have broken House ethics rules by persuading National Institutes of Health officials to meet with a staffer from that company. At least as troubling are the actions Collins took that were not deemed to be ethical violation

rest. But the Republican on the ethics task force, Rep. Van Taylor of Texas, expressed no disagreement with the panel's Democrat, Pennsylvania Rep. Susan Wild, who said she expected to move "rather quickly" on writing new rules. Taylor sees the tasks as "very narrow," focused on preventing lawmakers from